Alcohol has long been discussed as having a “J-curve” relationship to health. That is, alcohol is dangerous when consumed in large amounts, but light to moderate alcohol (e.g., a glass of wine per day) may be associated with improved heart health and cognition into later ages. However, new data are quickly eroding this model. There is a transition from alcohol as something that may help health to something that has multifaceted effects on health and the brain.
A recent New York Times article by Roni Caryn Rabin highlights recent controversy over alcohol guidelines. The American Heart Association (AHA) recently released a scientific statement that indicated that light alcohol (1-2 drinks/day) did not increase risk for coronary disease and may provide protection against heart failure. However, it was also quickly identified that numerous confounders exist in studies that support the J-curve, including overall health and socioeconomic status that are correlated with light alcohol consumption. Recent Mendelian randomization studies that use genetic variants associated with alcohol metabolism (rather than self-reported alcohol use) have also found increased disease and cognitive risks at low levels of predicted alcohol consumption, removing the protective end of the J-curve.
At the population level as well, evidence is emerging for the fallibility of “healthy” alcohol use. For neuroscience, there remains a need to learn the influence of alcohol on the brain as well as ways to treat alcohol use disorder (AUD) that do not have large impacts across the brain. Hoffman et al. (2023) recently published a preclinical study of a potential intervention for alcohol use that includes some aspects of the neural delivery of alcohol. Current medications that seek to alter glutamatergic transmission across the brain have a large side effect of globally inhibiting AMPA receptors that lead to motor and cognitive side effects. In this study, Hoffman and colleagues administered JNJ-55511118 to mice and found that selective inhibition of AMPA receptors that are bound to TARP γ-8 selectively attenuated voluntary operant alcohol self-administration in male mice but did not impact locomotor activity or sucrose intake that was behavior-matched to the test alcohol. Additionally, females displayed higher levels of alcohol intake overall compared to males, but JNJ-55511118 did not alter alcohol self-administration in females. This demonstrates the importance of looking at sex effects within the context of addiction and treatment.
These results represent a shift in both neuroscience and public health. Epidemiological studies have long shown that alcohol does not provide a “free lunch” to the brain or the heart. However, studies such as those performed by Hoffman et al. provide powerful tools for effectively addressing the problems associated with alcohol overconsumption by directly manipulating the neural circuits involved in alcohol intake. Thus, both neuroscience and public health can start to move away from a general view of alcohol as beneficial and toward treatment that enhances the long-term health of specific circuits within the brain, with implications for how addiction treatment might incorporate sex-specific biology in the future.
References
Hoffman, J. L., Faccidomo, S. P., Taylor, S. M., DeMiceli, K. G., May, A. M., Smith, E. N., Whindleton, C. M., & Hodge, C. W. (2023). Negative modulation of AMPA receptors bound to transmembrane AMPA receptor regulatory protein γ-8 blunts the positive reinforcing properties of alcohol and sucrose in a brain region-dependent manner in male mice. Psychopharmacology, 240(6), 1261–1273. https://doi.org/10.1007/s00213-023-06365-z
Rabin, R. C. (2025, December 16). Heart Association revives theory that light drinking may be good for you. The New York Times. https://www.nytimes.com/2025/12/16/health/alcohol-heart-disease-cancer.html